Levin Capital Strategies, L.P. United Therapeutics Corp Transaction History
Levin Capital Strategies, L.P.
- $1.03 Billion
- Q3 2024
A detailed history of Levin Capital Strategies, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 1,000 shares of UTHR stock, worth $362,160. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$362,160% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding UTHR
# of Institutions
672Shares Held
42.4MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.98 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.6 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.15 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$811 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...